Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joerg Thomas Bittenbring

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Cancer Immunology, Immunotherapy : CII|August 23, 2018
Determination of optimum vitamin D3 levels for NK cell-mediated rituximab- and obinutuzumab-dependent cellular cytotoxicityFrank Neumann, Fabian Acker, Claudia Schormann, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
Advances in Lymphoma Molecular DiagnosticsIgor Age Kos, Lorenz Thurner, Joerg Thomas Bittenbring, et al.
Clinical and Experimental Rheumatology|May 11, 2019
Progranulin-autoantibodies in sera of rheumatoid arthritis patients negative for rheumatoid factor and anti-citrullinated peptide antibodiesGunter Assmann, Silke Zinke, Moritz Gerling, et al.
Molecular and Clinical Oncology|December 15, 2021
Cost-effectiveness of precision cancer medicine-current challenges in the use of next generation sequencing for comprehensive tumour genomic profiling and the role of clinical utility frameworks (Review)Konstantinos Christofyllakis, Joerg Thomas Bittenbring, Lorenz Thurner, et al.
Ejhaem|August 19, 2024
Successful treatment of refractory donor-specific-human leukocyte antigen-antibody-induced primary graft-failure with daratumumab: A case reportVadim Lesan, Ketevani Melivadze, Johannes Hein, et al.
Nutrients|August 26, 2023
Vitamin D Enhances Immune Effector Pathways of NK Cells Thus Providing a Mechanistic Explanation for the Increased Effectiveness of Therapeutic Monoclonal AntibodiesKonstantinos Christofyllakis, Frank Neumann, Moritz Bewarder, et al.
Bone Marrow Transplantation|July 25, 2020
Insertion site of central venous catheter correlates with catheter-related infectious events in patients undergoing intensive chemotherapyTorben Rixecker, Vadim Lesan, Manfred Ahlgrimm, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 31, 2022
Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell LymphomaDominic Kaddu-Mulindwa, Philipp Gödel, Nadine Kutsch, et al.
Expert Review of Vaccines|August 22, 2022
Adaptive humoral immune response and cellular immune status in cancer patients and patients under immunosuppression vaccinated against SARS-CoV-2Igor Age Kos, Maximilian Kiefer, Katharina Brill, et al.
Annals of Hematology|September 3, 2024
An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphomaKonstantinos Christofyllakis, Dominic Kaddu-Mulindwa, Vadim Lesan, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cancer Immunology, Immunotherapy : CII|August 23, 2018
Determination of optimum vitamin D3 levels for NK cell-mediated rituximab- and obinutuzumab-dependent cellular cytotoxicityFrank Neumann, Fabian Acker, Claudia Schormann, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
Advances in Lymphoma Molecular DiagnosticsIgor Age Kos, Lorenz Thurner, Joerg Thomas Bittenbring, et al.
Clinical and Experimental Rheumatology|May 11, 2019
Progranulin-autoantibodies in sera of rheumatoid arthritis patients negative for rheumatoid factor and anti-citrullinated peptide antibodiesGunter Assmann, Silke Zinke, Moritz Gerling, et al.
Molecular and Clinical Oncology|December 15, 2021
Cost-effectiveness of precision cancer medicine-current challenges in the use of next generation sequencing for comprehensive tumour genomic profiling and the role of clinical utility frameworks (Review)Konstantinos Christofyllakis, Joerg Thomas Bittenbring, Lorenz Thurner, et al.
Ejhaem|August 19, 2024
Successful treatment of refractory donor-specific-human leukocyte antigen-antibody-induced primary graft-failure with daratumumab: A case reportVadim Lesan, Ketevani Melivadze, Johannes Hein, et al.
Nutrients|August 26, 2023
Vitamin D Enhances Immune Effector Pathways of NK Cells Thus Providing a Mechanistic Explanation for the Increased Effectiveness of Therapeutic Monoclonal AntibodiesKonstantinos Christofyllakis, Frank Neumann, Moritz Bewarder, et al.
Bone Marrow Transplantation|July 25, 2020
Insertion site of central venous catheter correlates with catheter-related infectious events in patients undergoing intensive chemotherapyTorben Rixecker, Vadim Lesan, Manfred Ahlgrimm, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 31, 2022
Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell LymphomaDominic Kaddu-Mulindwa, Philipp Gödel, Nadine Kutsch, et al.
Expert Review of Vaccines|August 22, 2022
Adaptive humoral immune response and cellular immune status in cancer patients and patients under immunosuppression vaccinated against SARS-CoV-2Igor Age Kos, Maximilian Kiefer, Katharina Brill, et al.
Annals of Hematology|September 3, 2024
An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphomaKonstantinos Christofyllakis, Dominic Kaddu-Mulindwa, Vadim Lesan, et al.
Pageof 3